TS
Thomas Smith Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
5
Avg Return
Past Year
Past Year
26%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
71.4%
Neutral
28.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $36 |
149%
upside
| 1 | -11% |
0
%
| 3 Mar ‘26 6 days ago |
|
|
|
Market Perform
Downgraded
| $58 | – | 2 | +135% |
0
%
| 21 Jan ‘26 1 month ago |
|
|
|
Outperform
Initiated
| $12 |
88%
upside
| 1 | +32% |
0
%
| 12 Jan ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $32 |
19%
upside
| 1 | +65% |
0
%
| 7 Jan ‘26 2 months ago |
|
|
|
Outperform
Initiated
| $42 |
71%
upside
| 1 | +19% |
0
%
| 1 Dec ‘25 3 months ago |
|
|
|
Market Perform
Downgraded
| $1 |
50%
downside
| 1 | – |
–
| 28 Mar ‘25 11 months ago |
|